Literature DB >> 7486044

Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures.

J F Antognini1.   

Abstract

Skeletal muscle may release creatine kinase (CK) during a malignant hyperthermia (MH) episode; however, muscle damaged during surgery may also release CK. This study examined the overlap between peak plasma CK levels in patients suspected of having had a MH episode (data obtained from North American MH Registry) and previously published CK changes occurring after common surgeries. For patients who were subsequently proven to be MH positive by muscle biopsy, there was considerable overlap. This was most significant with surgeries having substantial tissue damage, such as major vascular surgery and abdominal surgery. Overlap was much less with minimally invasive surgery, such as cystoscopy. Approximately 30% of MH positive patients treated with dantrolene had peak CK in the range of most surgical procedures, and approximately 50% of MH positive patients not given succinylcholine had peak CK similar to those of most surgical procedures. Dantrolene did not significantly alter peak CK in MH positive patients; however, succinylcholine was associated with significantly higher peak CK. These data suggest that patients who have had an acute MH episode during a surgical procedure may have peak CK values within the range of CK values expected from the procedure itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7486044     DOI: 10.1097/00000539-199511000-00025

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

Review 1.  A "crush" course on rhabdomyolysis: risk stratification and clinical management update for the perioperative clinician.

Authors:  Devan R Cote; Eva Fuentes; Ali H Elsayes; Jonathan J Ross; Sadeq A Quraishi
Journal:  J Anesth       Date:  2020-05-18       Impact factor: 2.078

Review 2.  PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics.

Authors:  Maria L Alvarellos; Ellen M McDonagh; Sephalie Patel; Howard L McLeod; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-12       Impact factor: 2.089

3.  Venovenous perfusion-induced systemic hyperthermia: five-day sheep survival studies.

Authors:  Cherry Ballard-Croft; Dongfang Wang; Kyle Rosenstein; Jingkun Wang; Robert Pollock; J Ann Morris; Joseph B Zwischenberger
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-05       Impact factor: 5.209

4.  The effect of succinylcholine on malignant hyperthermia events in susceptible swine.

Authors:  Frank Schuster; Stephan Johannsen; Susanne Moegele; Thomas Metterlein; Norbert Roewer; Martin Anetseder
Journal:  BMC Anesthesiol       Date:  2014-03-07       Impact factor: 2.217

5.  Malignant hyperthermia in a 6-month-old infant.

Authors:  P R Mathur; M Rundla; N Jain; V Mathur
Journal:  Saudi J Anaesth       Date:  2016 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.